Guía Dietética Para los Americanos 2010. ( USDA )

Estimados  Colegas:

Les dejo, el  enlace a las  Guías  Dietéticas  Para los Americanos.

Las  Diapositivas  son  un  instrumento  invaluable  Dietary Guidelines (59  diapositivas).ppt

Post. Scriptum.

Pendiente  de  entrega :   Módulo  comentado  en  español   de las diapositivas, ( 2010 DGAC)

y  módulo de bioquímica  y metabolismo.

Usaremos   esta  modalidad  para aumentar  la  interacciòn con  los  estudiantes   del  ciclo  básico  y  favorecer las  discusiones con los  mdicos  de base  y especialistas... Es decir  Criticar estas  guías,en  sentido griego   ( Krinei ) ...

Comentarios Slides:

Módulo de  Bioquímica:

Desde  Nicaragua

Dr.  Juan Herrera  Salazar.

Síndrome Metabólica . Documentos del Baylor College

Estimados  colegas:

Les presento una  serie de  documentos  del  Baylor  College  sobre  Síndrome  Metabólico.

Se trata de  Nueve  Conferencias  del  Selecto  grupo editorial  de esa institución:

Editorial Director

Christie M. Ballantyne, MD

Editors

Louis J. Aronne, MD, FACP

Philip J. Barter, MD, PhD

Thomas P. Bersot, MD, PhD

H. Bryan Brewer, Jr, MD

Eliot A. Brinton, MD..                                                                                                                          et  allies.

 Cardiometabolic Risk

Si  el lector  desea  leer  previamente las  conclusiones,  para  destacar la  relevanacia  para  sus  propias actividades  didácticas   quizás  quieran descargar  el  documento: 

Conclusiones que pueden considera antes de descargar las presentaciones:

 1.    Epidemiology of Insulin Resistance, Diabetes Mellitus and CHD

STEVEN M. HAFFNER, MD

2,C-Reactive Protein: A Marker of Risk

PETER W. F. WILSON, MD

3.Strategies for Lifestyle Modification in the Prevention of Diabetes and Cardiovascular Disease

ANTHONY N. FABRICATORE, PHD, AND THOMAS A. WADDEN, PHD

4.The Metabolic Syndrome: Introduction and Definitions

STEVEN M. HAFFNER, MD

5.Effects of Physical Activity and Exercise on Reducing Risk for Cardiovascular Disease and Diabetes, with a Focus on the Obese Patient

TIM CHURCH, MD, MPH, PHD

6.Therapeutic Options for Modifying Cardiovascular and Metabolic Risk Factors

LOUIS J. ARONNE, MD

7.Prevention of Diabetes

STEVEN HAFFNER, MD

8.Relationship of Glycemia to Cardiovascular Disease: Role of Antidiabetic Agents in Cardiovascular Risk Reduction

RICHARD W. NESTO, MD

9.Increased Cardiovascular Disease Risk in Type 2 Diabetes: Pathophysiology

WILLA A. HSUEH, MD

View as a CME activity

Gracias  por la  oportunidad                                                                                                                              Desde  Nicaragua.                                                                                                                                       Dr.  Juan Herrera  Salazar.

Material Educativo del Baylor College : Manejo de las Dislipidemias.

Estimados  colegas, voy  dejarles  esta página a vuestra  consideración :  Sobre   uno  de las  patologías ( trastornos metabólicos) más  frecuentes en medicina, (  DISLIPIDEMIAS) .
Conviene hacer  marcos  de referencia  gnoseológicos,   para  facilitar  su estudio:


1.   Riesgo cardio metabólico.
2.  Manejo  de las  dislipidemias   evolución de los  conceptos.
3.  Guías  para la  valoración del  riesgo  y manejo.
4.  Dislipidemia , inflamación  y ateroesclerosis.
5. Dislipidemia, Diabetes  y  ECV.
6. HDL , Enfermedad  Coronaria

                                        Desde  el  Baylor  College  Lipids  On  Line:

Dejo  a Uds  las  Series  del  Baylor  College:

Clinical Cases

A Case of a Patient with Diabetic Dyslipidemia

MADHURI VASUDEVAN, MD

A Patient With Coronary Artery Disease and Low High-Density Lipoprotein

TARA DALL, MD

A Case of Metabolic Syndrome and Elevated High-Sensitivity C-Reactive Protein: Approach to Management

MADHURI M. VASUDEVAN, MD, MPH

Consideration of Polypharmacology in Relation to Effective Weight Reduction: A Patient on Antipsychotic Medication

VIJAY NAMBI, MD AND MADHURI M.VASUDEVAN, MD, MPH

Consideration of Polypharmacology in Regards to Effective Weight Reduction: A Patient on Diabetes Medication

PETER H. JONES, MD

A Mexican American Woman with Multiple Metabolic Risk Factors

STEPHEN HAFFNER, MD

Benefits of Moderate Weight Loss in Reducing Cardiometabolic Risk

PETER H. JONES, MD

The Patient with Severe Hypertriglyceridemia

CHRISTIE M. BALLANTYNE, MD

Management of the Patient with Familial Hypercholesterolemia

PETER H. JONES, MD

The Patient with a Statin Intolerance

PETER H. JONES, MD

Lipid Treatment and Goal Attainment: A Hispanic Male with CHD and Diabetes

PETER H. JONES, MD

Cardiometabolic Risk

Increased Cardiovascular Disease Risk in Type 2 Diabetes: Pathophysiology

WILLA A. HSUEH, MD

View as a CME activity

Relationship of Glycemia to Cardiovascular Disease: Role of Antidiabetic Agents in Cardiovascular Risk Reduction

RICHARD W. NESTO, MD

Prevention of Diabetes

STEVEN HAFFNER, MD

Therapeutic Options for Modifying Cardiovascular and Metabolic Risk Factors

LOUIS J. ARONNE, MD

Effects of Physical Activity and Exercise on Reducing Risk for Cardiovascular Disease and Diabetes, with a Focus on the Obese Patient

TIM CHURCH, MD, MPH, PHD

The Metabolic Syndrome: Introduction and Definitions

STEVEN M. HAFFNER, MD

Strategies for Lifestyle Modification in the Prevention of Diabetes and Cardiovascular Disease

ANTHONY N. FABRICATORE, PHD, AND THOMAS A. WADDEN, PHD

C-Reactive Protein: A Marker of Risk

PETER W. F. WILSON, MD

Epidemiology of Insulin Resistance, Diabetes Mellitus and CHD

STEVEN M. HAFFNER, MD

Evolving Concepts in Lipid Management

Role of Omega-3 Fatty Acids in Cardiovascular Disease Prevention

WILLIAM S. HARRIS, PHD

C-Reactive Protein: A Target of Therapy

CHRISTOPHER P. CANNON, MD

Combination Lipid-Altering Drug Therapy with Statins: An Update

HAROLD BAYS, MD

Cholesterol Metabolism and the Concept of Dual Inhibition

DAVID E. COHEN, MD, PHD

Guidelines for Risk Assessment and Management

Initiating and Monitoring Statin Therapy

KIMBERLY K. BIRTCHER, MS, PHARMD, BCPS, CDE, CLS

View as a CME Activity

AHA/ACC Secondary Prevention Guidelines and the Evidence to Support Them

GREGG C. FONAROW, MD

Lifestyle Interventions: Dietary Therapy, Physical Activity, Weight Control

NEIL J. STONE, MD

Selecting Successful Lipid-Lowering Treatments

JAMES M. MCKENNEY, PHARMD

ATP III: New Approaches in Identifying and Treating High-Risk Patients

STEVEN M. HAFFNER, MD

New Evidence and the Guidelines: Is a Revision Needed?

Heart Protection Study

RORY COLLINS, MB BS

Dyslipidemia, Inflammation and Atherosclerosis

Sitosterolemia: A Rare Genetic Disorder Leads to Insight into an Important Physiological Process

SHAILESH B. PATEL, BM, CHB, FRCP

Inflammatory Markers, Pharmacotherapy and Clinical Trials

PAUL RIDKER, MD
CHRISTIE M. BALLANTYNE, MD

Inflammation and Pathogenesis of Atherothrombotic Disease

PETER LIBBY, MD

Role of Lipoproteins in Inflammation

PHILIP J. BARTER, MD, PHD

Epidemiology of Inflammatory Markers and CHD: Evidence for High-Sensitivity C-Reactive Protein

PAUL RIDKER, MD

Dyslipidemia, Diabetes and CHD

Diabetic Dyslipidemia and Atherosclerosis

HENRY GINSBERG, MD

Clinical Trials and Guidelines for Lipid Management in the Diabetic Patient

STEVEN M. HAFFNER, MD

Clinical Evaluation and Nonlipid Treatment of CAD in the Diabetic Patient

RICHARD NESTO, MD

HDL and Coronary Heart Disease

High-Density Lipoprotein and the Epidemiology of Coronary Heart Disease

MICHAEL MILLER, MD, FACC, FAHA

View as a CME Activity

Coronary Imaging and Coronary Event Trials

B. GREG BROWN, MD

Current and Emerging Pharmacologic Approaches to Targeting HDL

MICHAEL H. DAVIDSON, MD

Evidence to Support Aggressive Management of HDL-C: Implications of Recent Trials

ALLEN J. TAYLOR, MD

HDL as a Therapeutic Target

DANIEL J. RADER, MD

Epidemiology of CHD

THOMAS P. BERSOT, MD, PHD
STEVEN M. HAFFNER, MD

Physiology and Pathophysiology of HDL Metabolism

DANIEL J. RADER, MD

Effects of Lifestyle and Dietary Modification on HDL-C Levels

MARGO A. DENKE, MD.

Gracias  por la oportunidad

Material Educativo del Baylor College. Manejo de la Hipertensión Arterial

Estimados  colegas, voy  dejarles  esta página a vuestra  consideración :  Sobre   Hipertensión  Arterial  una  de las  patologías  mas  frecuentes en Medicina,  

Desde  el  Baylor  College  Hipertensión  On  Line:

Quizás  les interese  explorar los sets de  diapositivas  (  un  total  de  nueve) en los  enlaces   que encontrarán  mas  adelante:

Las  pláticas  dan  una  visiòn  unitaria , muy útil  para  el médico  general el internista y  el  cardiólogo:

Farmacología  clínica,

Consecuencias  cardiovasculares

Diabetes 

Enfermedad  Renal.

The Hypertension Online Slide Library is a collection of slide talk resources for physicians and researchers to use as self-study tools or in educating others. The Slide Library is organized into slide sets addressing specific areas of organ and systemic damage associated with hypertension. Each talk includes slides, talking points and references linked to PubMed. Entire slide talks, individual slides, and custom presentations can be downloaded into PowerPoint for personal and educational use.

The Hypertension Online Slide Library includes the following slide sets and talks that explore the interrelated nature of the relationship between elevated blood pressure and systemic/organ damage:

Quizás les  interese  ver el  documento  recopilado  de las  conclusiones  

Clinical Pharmacology

Rationale for Lowering Blood Pressure

Principles of Antihypertensive Therapy

Response to Single-Drug Antihypertensive Treatment: Variations Based on Age and/or Ethnicity

Effects of Lifestyle Modifications on Blood Pressure

Diuretics for the Treatment of Hypertension

Cardiac Consequences

Clinical Trials
The Relationship of Hypertension Treatment to CVD Risk Reduction

    Introduction

    VA Cooperative Study on Antihypertensive Agents

    Hypertension Detection and Follow-up Program

    Australian National Blood Pressure Study

    European Working Party on High Blood Pressure in the Elderly

    Systolic Hypertension in the Elderly Program

    Systolic Hypertension in Europe Trial

Diabetes

Epidemiology
Prevalence and Relative Risk
Impact on Clinical Cardiovascular Disease

Clinical Trials

ACE Inhibitors

Angiotensin Receptor Blockers

Calcium Channel Blockers

Diuretics

Beta-Blockers

Old and New Therapy

Renal Disease

Epidemiology

Mechanisms

Clinical Trials

Therapeutics

For more information on accessing and utilizing these slides, and for information on searching the Slide Library using custom terms and keywords, please visit How to Use the Slide Library.

Gracias  nuevamente por la oportunidad.

Desde  Nicaragua
Juan Herrera Salazar.

Enfermedad Pulmonar Crónica Obstuctiva COPD

Quizás les interese  tener  una  revisión  del  material producido en  relación  a la  EPOC,(COPD)  en diferentes  formatos, en una  sola  página de  referencia:

                              Guías Gold,  Guías  NICE.

Latest Publications

Global Strategy for Diagnosis, Management, and Prevention of COPD

Updated December 2011.

Pocket Guide to COPD Diagnosis, Management, and Prevention

Updated December 2011.

Spirometry Guide

Updated June 2010.

 

Si el  lector  quiere  todo  en una sola hoja , Pocket Card :

 

Documents

COPD Diagnosis and Management At-A-Glance Desk Reference

Updated January 2012 (based on 2011 documents)

·         COPD risk factors

·         Classification of COPD by severity

·         Therapy at each stage of COPD

·         Management of COPD exacerbations

 

NHS.

National  Institute  for  Health and  Clinical  Excellence ( NICE).

Management of chronic obstructive pulmonary disease in adults in primary and secondary care (partial update).

This guideline partially updates and replaces NICE clinical guideline 12

·         Web format

·         Quick reference guide (PDF)

·         NICE Guideline (PDF)

·         Full Guideline (PDF)

 

Buen  fin  de  Semana.

Desde,  Nicaragua

Dr.  Juan  Herrera  Salazar

Guías de Práctica Clínica. SIGN . Scottish Intercollegiate Guidelines Network

Estimados  Colegas  quiero  aprovechar la  Oportunidad para  
PRESENTARLES   ESTA  RED :  LAS  GUÍAS   SIGN

Uds    encontrarán  la  guías  completas en  esta  red:  por  sujeto  y/o número.  Nosotros   selecciónamos   los enlaces  de las  guías  que interesan   nuestra práctica  clínica,  vinculada  a  la  medicina  interna  y  enfermedades  respiratorias.

 Hemos  destacado  algunas  relacionadas  al  metabolismo  (  Diabetes  , Síndrome  Metabolica ).   Por  el  interés  que  cada  día  más despiertan  hemos  subrayado  las  relacionadas a la  apnea del  sueño  que cada vez  son   apreciadas    como  guías  interdisciplinarias

Les  propongo  el  primer  post  de  una  serie

BRITISH GUIDELINE ON THE MANAGEMENT OF ASTHMA  

 Scottish Intercollegiate Guidelines Network Guidelines Network

DOWNLOAD THE GUIDELINE

		App	PDF
	Full guideline			(2.29M)
	Quick reference guide			(1.19M)
	Information about Acrobat files

REMIT OF THE GUIDELINE

Produced jointly by SIGN and the British Thoracic Society (BTS) since 2003, sections of the guideline are updated annually.

Guideline No. 101
ISBN 978 1 90581 28 5

May 2008, Revised May 2011
Section 4.3.4 revised Sept 2011
Section 1 revised Jan 2012

PATIENT INFORMATION

	Managing asthma in adults		(878K)
	Managing asthma in children		(951K)
	Steps diagram adults (Acrobat Professional or Acrobat Reader 7 or higher required for electronic completion)		(49K)

SUPPORTING MATERIAL

	Key questions		(147K)
	Search strategies and evidence tables
	Case studies and educational slides
	Implementation Meeting slides		(5.25M)
	Implementation Meeting report		(499K)
	Be in Control materials
	Occupational asthma record forms. Buen  fin  de  semana. Desde Nicaragua,  Atentamente.  Dr.  Juan  Herrera  Salazar